BARX2: A Key Homeobox Transcription Factor in Development and Disease

Comprehensive genomic and functional analysis of BARX2, a homeobox gene implicated in craniofacial development, cancer, and tissue-specific gene regulation.

Gene Information Card

Symbol BARX2
Full Name BARX homeobox 2
Gene Type protein-coding
Chromosomal Location 11q24.3
NCBI Gene ID 8538 ncbi.nlm.nih.gov/gene/8538
Ensembl ID ENSG00000149257
UniProt ID Q9UMQ3
OMIM ID 604363
HGNC ID 956
Aliases BARX2a, BARX2b, MGC138499

Description

BARX2 (BARX homeobox 2) is a homeobox-containing transcription factor that plays a critical role in embryonic development, particularly in craniofacial and limb morphogenesis. It regulates cell adhesion, migration, and differentiation by modulating genes such as cadherins and matrix metalloproteinases. BARX2 is also implicated in cancer progression, where its expression is often dysregulated in breast, ovarian, and prostate cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Craniofacial abnormalities BARX2 regulates neural crest cell migration and craniofacial patterning; mutations may disrupt development. OMIM #604363; animal models
Breast cancer BARX2 expression is reduced in invasive breast cancer; loss promotes epithelial-mesenchymal transition (EMT). PubMed studies; COSMIC
Ovarian cancer BARX2 downregulation correlates with poor prognosis and increased metastasis. ClinVar; PubMed
Prostate cancer BARX2 acts as a tumor suppressor; hypermethylation silences expression. COSMIC; PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 2.1 Low
Heart 1.8 Low
Kidney 3.5 Medium
Liver 1.2 Low
Lung 4.0 Medium
Mammary gland 5.2 Medium
Ovary 6.8 High
Prostate 4.5 Medium
Skin 3.0 Medium
Testis 2.5 Low
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 3.8 Moderate expression
OVCAR3 (ovarian cancer) 5.1 High expression
PC3 (prostate cancer) 2.9 Low expression
HEK293 (embryonic kidney) 4.2 Moderate expression
HeLa (cervical cancer) 1.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.1% Potential loss of start codon; likely loss-of-function
c.214C>T (p.Arg72Trp) Missense <0.1% May alter DNA-binding affinity
c.487_489del (p.Lys163del) Deletion <0.1% In-frame deletion in homeodomain; likely damaging
c.631C>T (p.Arg211*) Nonsense <0.1% Premature stop; loss-of-function
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Arg211*) lead to truncated protein; missense in homeodomain (e.g., p.Arg72Trp) reduce DNA binding.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in BARX2.

Dominant Negative (DN)

Not documented; BARX2 likely acts as a monomer, so dominant-negative effects are not typical.

Pathways

Regulation of epithelial-mesenchymal transition (EMT)
Cadherin signaling pathway
Neural crest cell migration
Wnt signaling pathway (modulation)

Protein Summary

BARX2 is a 263-amino acid homeobox transcription factor containing a conserved DNA-binding homeodomain. It localizes to the nucleus and binds to specific promoter sequences to regulate genes involved in cell adhesion (e.g., CDH1/E-cadherin), migration, and differentiation. The protein is expressed in developing craniofacial structures, limbs, and adult tissues such as ovary and prostate. Dysregulation of BARX2 contributes to cancer metastasis and developmental disorders.

Related Products

Product name Cat.No. Species Gene ID
BARX2 Knockout HEK293 Cell Line EDJ-KQ6288 Human 8538 Details Get a Quote
BARX2 Knockout HeLa Cell Line EDJ-KQ54936 Human 8538 Details Get a Quote
BARX2 Knockout A-549 Cell Line EDJ-KQ63421 Human 8538 Details Get a Quote
BARX2 Knockout HCT 116 Cell Line EDJ-KQ71886 Human 8538 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: